2019 Participants

Home » 2019 Participants

Discover who attended BioFIT 2019

2019 Sponsors

Gold Sponsors

Globe Linkedin Twitter Facebook Instagram

Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Globe Linkedin Twitter Facebook Instagram

Sanofi

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.

Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

Sanofi’s presentation “Why partner with Sanofi?”
Speaker: Murielle Gitton, Head R&D Transactions
Tuesday, November 29th | 3.15 – 3.30 pm | Innov’Area

Silver Sponsors

Globe Linkedin Twitter Facebook Instagram

GENFIT

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Today, GENFIT has a growing and diversified pipeline with programs at various development stages. The Company’s area of focus is Acute on Chronic Liver Failure (ACLF). Its ACLF franchise consists of five assets in development. Other assets target other life-threatening disease indications such as cholangiocarcinoma (CCA) and Urea Cycle Disorders (UCD)/Organic Acidemias (OA).

Globe Linkedin Twitter Facebook Instagram

MSD

MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide… and many of these advances were the result of partnerships. In 2016, more than 60% of our human health sales were attributable to alliance partnerships and patents and we continue to work with our partners in some of the most challenging areas of biomedical research. With more than 100 business development transactions since 2015, our team has experience working on collaborations from discovery to clinical-stage programs regardless of therapeutic area or modality. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life.

Globe Linkedin Twitter Facebook Instagram

MSD Animal Health

MSD Animal Health, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets.

Bronze Sponsors

Globe Linkedin Twitter Facebook Instagram

Almirall

Almirall is a leading global pharmaceutical company, focused in medical dermatology and headquartered in Barcelona. Our strong commitment is to improve patients’ quality life while caring and listening to them. We work to offer innovative and differentiated medicines for skin conditions with high unmet need. We cover the whole of the drug value chain through an expert R&D organisation as well as key partnerships.

Globe Linkedin Twitter Facebook Instagram

Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com.

Globe Linkedin Twitter Facebook Instagram

Boehringer Ingelheim

As an independent company active in both human and animal health, Boehringer Ingelheim has learned over generations that the challenging path towards health innovation requires long-term commitment, resilience, and transformative action. Decades of cutting-edge science and innovation has enabled us to deliver many pioneering breakthroughs in some of the most devastating diseases and challenging areas we face globally. Continuing this journey hinges on collaboration.

We believe that working together with our global community of partners brings critical diversity to innovation and accelerates the next breakthroughs in human and animal health that will transform lives now and in generations to come. This collective power, in the tireless pursuit of science and solutions, enables us to build together a healthier, more sustainable, and equitable tomorrow.

Globe Linkedin Twitter Facebook Instagram

EVOTEC

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,900 employees provide the highest quality stand-alone and integrated drug discovery and development solutions from target to clinic. For additional information, please go to www.evotec.com and follow us on Twitter @Evotec.

Globe Linkedin Twitter Facebook Instagram

Ipsen

Ipsen is a public global, mid-sized biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease and Neuroscience. With Specialty Care sales of €2.6bn in FY 2021, Ipsen sells medicines in over 100 countries. Ipsen has 5,000 employees worldwide and innovative research located in leading biotechnological and life-science hubs in France, UK, US and China. For more information, visit ipsen.com and get in touch with our partnering team!

Globe Linkedin Twitter Facebook Instagram

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases such as diabetes, obesity and cardiovascular disease as well as rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.

Globe Linkedin Twitter Facebook Instagram

Roche

Roche is the world’s largest biotech company and #1 investor into R&D, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the CNS. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. Our Pharma Partnering team provides comprehensive BD and alliance management support for Roche and Genentech’s R&D units and the broader pharmaceutical division. Alongside the broad internal pipeline, external innovation has always been a critical component of our R&D strategy.

Contributing Sponsors

Globe Linkedin Twitter Facebook Instagram

Advent France Biotechnology

Advent France Biotechnology is a French Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.

We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success.

We embrace French Life Sciences’ dynamic of innovation. France harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. Advent France Biotechnology seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring France’s biotechnology ecosystem. With Advent France Biotechnology Seed Fund I, we stand as the first dedicated Life Sciences seed-fund in France.

Advent France Biotechnology is supported by Advent Life Sciences, one of Europe’s leading venture teams investing in Life Sciences businesses, giving us direct access to their team of 15 investment professionals. Advent France Biotechnology will apply the investment methodology of Advent Life Sciences that has proven to be highly successful in seeding, creating and supporting early stage Life Sciences projects in the UK and the US for 4 decades.

Advent France Biotechnology was founded in 2015 and is AMF regulated since 2016.

Globe Linkedin Twitter Facebook Instagram

Alzprotect

Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer’s disease (AD) and tauopathies such as Progressive Supranuclear Palsy (PSP).

Alzprotect has developed specific global-level expertise in tauopathies, where neuronal degeneration is a consequence of an abnormal accumulation of hyperphosphorylated Tau proteins combined to neuroinflammation: Progressive Supranuclear Palsy (PSP) and Alzheimer’s disease (AD).

Their expertise led to the discovery of several molecules with novel mechanisms of action, such as AZP2006 that shows potent and promising effects to control neurodegeneration.

Globe Linkedin Twitter Facebook Instagram

Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

Globe Linkedin Twitter Facebook Instagram

LFB

The LFB Group has been developing, manufacturing and marketing biological medicinal products, for diseases that are always serious and often rare in three major fields of therapy: immunology, haemostasis and intensive care. The LFB group is today a European key player in the field of therapeutic proteins. Over 2,000 employees of the LFB Group, both in France and worldwide, are totally committed to meeting the needs of hundreds of thousands of patients.

Globe Linkedin Twitter Facebook Instagram

Ontoforce

For more than a decade, ONTOFORCE has addressed the problem many life sciences companies struggle with when bringing together structured and unstructured data to create new insights. These insights lead to accelerated drug discovery, more in-depth insights into research, real-world evidence, optimized clinical trial research, and a faster go-to-market.
ONTOFORCE already works for lighthouse customers such as Amgen, UCB, BMS, Roche, Medidata, and numerous other life sciences colleagues. Thanks to the intense collaboration with renowned research institutes such as IMEC, VIB, UGent, KULeuven, and international research and industrial consortia such as ELIXIR, FAIRplus, and Pistoia Alliance, it guarantees that you are engaging with a global player that has made transforming data into insights its primary objective.